Post-acute Sequelae of Sars-cov-2 Infection
📧 Sign up to get email alerts when something new happens for Post-acute Sequelae of Sars-cov-2 Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-08-26Clinical Trial Update: A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid [Phase 2]
A Phase 2 clinical trial evaluating amantadine for cognitive dysfunction in Long COVID/Post-Acute COVID-19 Syndrome was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-17Clinical Trial Update: Double-Blind Randomized Placebo-Controlled Trial of a Proprietary Full Hemp Flower Formulation for Long COVID [NA]
A double-blind randomized placebo-controlled trial of a proprietary full hemp flower formulation for post-acute COVID-19 syndrome has been w…
-
CLINICAL_TRIALS withdrawal · 2025-04-23Clinical Trial Update: Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Post COVID-19 [NA]
A clinical trial evaluating autologous adipose-derived stromal vascular fraction for post-COVID-19 was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-03-26Clinical Trial Update: Cardiopulmonary Rehabilitation in Post-acute COVID-19 Syndrome [NA]
A clinical trial evaluating cardiopulmonary rehabilitation for post-acute COVID-19 syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-22Clinical Trial Update: ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome [Phase 1, Phase 2]
A Phase 1/2 trial of ExoFlo Infusion for post-acute COVID-19 and chronic post-COVID-19 syndrome has been withdrawn by the sponsor.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-05-08Clinical Trial Update: Exercise Interventions in Post-acute Sequelae of Covid-19 [NA]
The clinical trial investigating exercise interventions for post-acute sequelae of COVID-19 has been withdrawn.